BNN Bloomberg: U.S. IPO market expected to see more unicorns: IPOX Schuster
Josef Schuster, founder and CEO of IPOX Schuster, joins BNN Bloomberg to discuss the state of the IPO market in 2020. He notes the U.S. will likely see the most activity, followed by Europe, in the year ahead. https://www.bnnbloomberg.ca/video/u-s-ipo-market-expected-to-see-more-unicorns-ipox-schuster~1864585 Please use above
Non-Household Names Topped the List of IPO Winners in 2019
Ben Hernandez | ETFTrends.com Karuna Therapeutics, NextCure, and Cortexyme aren’t household names when it comes to investors looking at initial public offerings (IPOs), but they’ve been generating big-time returns for investors who didn’t buy into the hype of more familiar names
Factor Exposures for the IPOX Portfolio
Michael Kollo, Kat Liu, Josef Schuster Abstract Factor investing has become increasingly popular in recent years. Institutional investors have been shifting to more transparent and systematic factor approaches where they can clearly see the exposures which they are carrying. We quantify the
IPOX Indexes Rulebook December 2019
IPOX Indexes Rulebook Version December 2019
IPO of the Week
Arconic Cover